Soft Tissue Allografts Market is expected to reach US$ 6,748.28 Million by 2031

Orthopedic Segment to Bolster Soft Tissue Allografts Market Growth During 2024–2031

According to our new research study on "Soft Tissue Allografts Market Forecast to 2031 – Global Analysis – by Type, Application, and End User," the market was valued at US$ 4,088.49 million in 2024 and is projected to reach US$ 6,748.28 million by 2031; it is anticipated to record a CAGR of 7.4% from 2024 to 2031.

The report emphasizes the soft tissue allografts market trends, along with drivers and deterrents affecting the market growth. The increasing aging population, and the rising incidence of sports injuries & trauma are contributing to the growing soft tissue allografts market size. However, the high cost of procedures hampers the market growth. Further, the development of customized grafts is expected to emerge as a new market trend in the coming years.

Soft Tissue Allografts Market Share, by Region, 2024 (%)

Source: The Insight Partners Analysis

Increasing Aging Population Bolsters Soft Tissue Allografts Market Growth

The aging demographic is more prone to muscle ligament and tendon (soft tissue) injuries. As per the World Health Organization (WHO) estimates, in 2030, 1 in 6 people would be aged 60 years or more globally. The population aged 60 years and above is projected to increase from 1 billion in 2020 to 1.4 billion in 2030 and 2.1 billion by 2050. The number of persons aged 80 or older is expected to triple between 2020 and 2050 to reach 426 million. Rotator cuff tears are widely observed in older populations (>65 years of age). As per the StatPearls study “Rotator Cuff Injury,” published in June 2023, rotator cuff injuries are the most common tendon injuries reported in adults; approximately 30% of adults over 60 years of age and 62% of adults over 80 of age suffer these injuries. Osteoarthritis (OA) is another age-related disorder that affects the cartilage that cushions joints. As per the WHO, ~73% of people living with osteoarthritis are older than 55 years, and 60% of these are female. Further, as per the US Department of Health and Human Services, the chance of developing an inguinal hernia in adults increases with age, and the condition is most common in people aged 75–80. Thus, the growing aging population across the world can be associated with the demand for soft tissue allografts.

Soft Tissue Allografts Market Report Scope:

The soft tissue allografts market analysis has been carried out by considering the following segments: type, application, end user, and geography. Based on type, the market is segmented into cartilage allograft, tendon allograft, dental allograft, meniscus allografts, placental tissue, and others. The cartilage allograft segment held the largest soft tissue allografts market share in 2024. Cartilage allografts are used primarily in joint preservation surgeries, particularly those performed for knee, hip, and shoulder cartilage defects. The increasing prevalence of osteoarthritis and sports-related injuries drives the demand for cartilage allografts. Advancements in cryopreservation and tissue preservation techniques have contributed to significant improvements in the shelf life of these allografts, bolstering their clinical applications. Moreover, advanced conformable allografts offered by some companies do not require surgeons to use templates or anchors to fill the spaces in the lesion. For example, MTF Biologics offers advanced ready-to-use off-the-shelf viable cartilage allografts that can fill cartilage defects in lesions of sizes upto 5 sq. cm.

In terms of application, the soft tissue allografts market is categorized into orthopedic, dentistry, wound care, and others. The orthopedic segment dominated the market in 2024. Key drivers for the growth of this segment include the rising incidence of sports injuries, degenerative joint diseases (e.g., osteoarthritis), and an aging population that requires joint replacement surgeries. The orthopedic segment of the soft tissue allografts market focuses on the use of allografts for joint reconstruction, tendon and ligament repairs, and spinal surgeries. Allografts of bone, tendon, cartilage, and meniscus tissues, among others, are commonly used in procedures such as ACL reconstruction, spinal fusion, and joint replacement surgeries. The primary advantage of using allografts in orthopedics is attributed to their ability to restore function while reducing post-surgical complications, such as donor site morbidity and other setbacks associated with autografts.

In terms of end user, the soft tissue allografts market is categorized into hospitals, specialty clinics, and others. The hospitals segment dominated the market in 2024. This segment is a major contributor to the soft allograft tissue market, as these institutions often serve as primary settings for complex surgeries such as orthopedic procedures, wound care, and dental surgeries. Hospitals utilize soft allografts for a wide range of applications, including joint reconstruction, spinal surgeries, wound healing, and organ repair. Soft allografts of skin, bone, tendon, and cartilage tissues are essential for supporting patient recovery by promoting tissue regeneration and reducing complications. The growth of the soft tissue allograft market in the hospital segment is largely driven by the increasing number of joint replacement and spine surgeries being performed, particularly in the elderly population. Additionally, advantages such as reduced surgical complications and faster recovery times result in a surge in the preference for soft tissue allografts in hospitals over autografts.

Soft Tissue Allografts Market Analysis: Based on Geography

The geographic scope of the soft tissue allografts market includes the assessment of the market performance in North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), South & Central America (Brazil, Argentina, and Rest of South & Central America), and the Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa).    

The National Health Service (NHS), American Academy of Orthopaedic Surgeons (AAOS), World Health Organization, US Department of Health and Human Services, and National Safety Council are among the primary and secondary sources referred to while preparing the soft tissue allografts market report.    

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com